Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered question first ministerially corrected answering member label attachment file name title previous answer version answering member printed answering member label
tabling member	label

Search

1126307

	registered interest
	date	13/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Civil Proceedings
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government how much money the NHS spent as part of legal settlements in each year from 2009 to 2018; and how much of each year's spend relates to legal fees.
	tabling member printed	Baroness Hodgson of Abinger
	uin	HL15667
	answer	answer is ministerial correction date of answer 24/05/2019 answer text <p>NHS Resolution has provided the following information:</p><p>NHS Resolution has provided tables which cover:</p><p>- total expenditure for NHS Resolution Clinical Negligence Schemes and NHS Resolution non-clinical negligence schemes from 2009 to 2018;</p><p>- the total legal costs per financial year; and</p><p>- the draft budget for legal fees/damages 2019 for NHS Resolution Clinical Negligence Schemes and NHS Resolution non-clinical negligence schemes.</p><p>The data is attached due to the size of the data.</p><p>National Health Service spend on legal fees for matters other than clinical/non-clinical negligence settlements since 2009 has been interpreted as spend relating to NHS providers and commissioners.</p><p>This includes NHS trusts, NHS foundation trusts and NHS England and clinical commissioning groups. NHS spend on legal fees for non-negligence matters is shown in the following table.</p><table><tbody><tr><td><p>Year</p></td><td><p>Total legal fees (£000s)</p></td></tr><tr><td><p>2013-14</p></td><td><p>110,747</p></td></tr><tr><td><p>2014-15</p></td><td><p>171,806</p></td></tr><tr><td><p>2015-16</p></td><td><p>162,273</p></td></tr><tr><td><p>2016-17</p></td><td><p>172,135</p></td></tr><tr><td><p>2017-18</p></td><td><p>160,140</p></td></tr></tbody></table><p>Prior to 2013-14, expenditure on legal fees was not separately classified by primary care trusts and strategic health authorities who both carried out NHS commissioning and NHS trusts. Therefore, comparable information pre 2013-14 is unavailable.</p><p>There is no specific category of expenditure that isolates spend relating to legal settlements in the NHS.</p><p>We have interpreted the request for data for the amounts set aside in 2019 as the value of said provisions as at the end of the financial year, 31 March 2019. This data is still subject to audit and will not be available until after publication of the Annual Report and Accounts in July 2019.</p><p>The budget totals for legal fees relating to NHS spend in 2019 is not available.</p><p> </p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL15668 question first answered 24/05/2019 11:47:45 answering member 4019 label Biography information for Baroness Blackwood of North Oxford attachment 1 file name HL15667 & HL15668 Data.docx title HL15667_HL15668_data
	tabling member	4301 label Biography information for Baroness Hodgson of Abinger

1126308

	registered interest
	date	13/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Civil Proceedings
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government how much money the NHS has set aside for potential legal settlements in 2019; and how much they have budgeted for legal fees.
	tabling member printed	Baroness Hodgson of Abinger
	uin	HL15668
	answer	answer is ministerial correction date of answer 24/05/2019 answer text <p>NHS Resolution has provided the following information:</p><p>NHS Resolution has provided tables which cover:</p><p>- total expenditure for NHS Resolution Clinical Negligence Schemes and NHS Resolution non-clinical negligence schemes from 2009 to 2018;</p><p>- the total legal costs per financial year; and</p><p>- the draft budget for legal fees/damages 2019 for NHS Resolution Clinical Negligence Schemes and NHS Resolution non-clinical negligence schemes.</p><p>The data is attached due to the size of the data.</p><p>National Health Service spend on legal fees for matters other than clinical/non-clinical negligence settlements since 2009 has been interpreted as spend relating to NHS providers and commissioners.</p><p>This includes NHS trusts, NHS foundation trusts and NHS England and clinical commissioning groups. NHS spend on legal fees for non-negligence matters is shown in the following table.</p><table><tbody><tr><td><p>Year</p></td><td><p>Total legal fees (£000s)</p></td></tr><tr><td><p>2013-14</p></td><td><p>110,747</p></td></tr><tr><td><p>2014-15</p></td><td><p>171,806</p></td></tr><tr><td><p>2015-16</p></td><td><p>162,273</p></td></tr><tr><td><p>2016-17</p></td><td><p>172,135</p></td></tr><tr><td><p>2017-18</p></td><td><p>160,140</p></td></tr></tbody></table><p>Prior to 2013-14, expenditure on legal fees was not separately classified by primary care trusts and strategic health authorities who both carried out NHS commissioning and NHS trusts. Therefore, comparable information pre 2013-14 is unavailable.</p><p>There is no specific category of expenditure that isolates spend relating to legal settlements in the NHS.</p><p>We have interpreted the request for data for the amounts set aside in 2019 as the value of said provisions as at the end of the financial year, 31 March 2019. This data is still subject to audit and will not be available until after publication of the Annual Report and Accounts in July 2019.</p><p>The budget totals for legal fees relating to NHS spend in 2019 is not available.</p><p> </p> answering member printed Baroness Blackwood of North Oxford grouped question UIN HL15667 question first answered 24/05/2019 11:47:45 answering member 4019 label Biography information for Baroness Blackwood of North Oxford attachment 1 file name HL15667 & HL15668 Data.docx title HL15667_HL15668_data
	tabling member	4301 label Biography information for Baroness Hodgson of Abinger

1126321

	registered interest
	date	13/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Gender Dysphoria: Children
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government whether they intend to publish the results of the research project started in 2011 by the NHS Gender Identity Development Service Early pubertal suppression in a carefully selected group of adolescents with gender identity disorder; and if not, whether they will arrange for the data gathered by that study to be made available to other researchers.
	tabling member printed	Lord Lucas
	uin	HL15681
	answer	answer is ministerial correction date of answer 22/05/2019 answer text <p>The research is an ethically approved study being carried out by the Tavistock and Portman NHS Foundation Trust since 2011, which is the largest provider of services for the alleviation of gender dysphoria in the United Kingdom.</p><p>The study will evaluate early pubertal suppression in a carefully selected group of adolescents with a clinical diagnosis of gender dysphoria. There are 44 young people taking part in the study.</p><p>The Tavistock and Portman NHS Foundation Trust has plans to publish the data <ins class="ministerial">on the blocker and cross-sex hormones, for those who were appropriate for this, as</ins><del class="ministerial">once</del> all of the young people in the study have reached <ins class="ministerial">this</ins><del class="ministerial">the</del> stage<ins class="ministerial">.</ins> <del class="ministerial">when a clinical decision is made about moving from pubertal suppressants to cross-sex hormones, which the Trust expects to occur in the next 12 months.</del></p> answering member printed Baroness Blackwood of North Oxford question first answered 22/05/2019 14:51:30 question first ministerially corrected 31/07/2019 15:30:59 answering member 4019 label Biography information for Baroness Blackwood of North Oxford previous answer version 119577 answering member printed Baroness Blackwood of North Oxford answering member 4019 label Biography information for Baroness Blackwood of North Oxford
	tabling member	1879 label Biography information for Lord Lucas

1126059

	registered interest
	date	13/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Breast Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many vacancies there are in (a) mammography and (b) breast radiology in each Clinical Commissioning Group.
	tabling member constituency	Burton
	tabling member printed	Andrew Griffiths
	uin	253555
	answer	answer is ministerial correction date of answer 16/05/2019 answer text <p>The information is not held in the format requested</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 16/05/2019 15:51:34 answering member 4455 label Biography information for Seema Kennedy
	tabling member	3936 label Biography information for Andrew Griffiths

1126283

	registered interest
	date	13/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Primary Care Networks
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what discussions he had with (a) the British Medical Association, (b) the Royal College of General Practitioners and (c) other representative groups before announcing the timetable for the creation of primary care networks.
	tabling member constituency	Oxford East
	tabling member printed	Anneliese Dodds
	uin	253710
	answer	answer is ministerial correction date of answer 16/05/2019 answer text <p>My Rt. hon. Friend the Secretary of State has met with both Richard Vautrey and Helen Stokes-Lampard as representatives of the profession to discuss a range of issues, including, but not limited to, the creation of Primary Care Networks.</p><p> </p><p>In addition, Departmental officials have been in regular communication with both the Royal College of General Practitioners (RCGP) and the British Medical Association (BMA) throughout the development of the Primary Care Networks policy and will continue these close working relationships as the networks are implemented.</p><p> </p><p>The Primary Care Network Directed Enhanced Service specification, which sets out the timetable for networks, was agreed with the General Practitioners Committee and the BMA as part of negotiations on the contract for 2019/20.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 16/05/2019 15:44:50 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4657 label Biography information for Anneliese Dodds

1126284

	registered interest
	date	13/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	General Practitioners: Finance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether he has plans to allocate additional funding to GP practices to enable the recruitment and appointment of Primary Care Network medical directors.
	tabling member constituency	Oxford East
	tabling member printed	Anneliese Dodds
	uin	253711
	answer	answer is ministerial correction date of answer 16/05/2019 answer text <p>Each Primary Care Network (PCN) is required to appoint a Clinical Director. Under the terms of the Network Contract Directed Enhanced Service (DES) contract specification published by NHS England in March 2019, PCNs can claim funding for this role. It is a population-based payment calculated using a baseline equivalent of 0.25 Whole Time Equivalent (WTE) per 50,000 registered population size, as at 1 January 2019 (one WTE being paid £137,516 in 2019/20). This is a payment of £0.51430 per registered patient for the period 1 July 2019 to 31 March 2020 (which equates to £0.057 per patient per month), reflecting the fact that the Network Contract DES begins in July 2019 - this will be the point at which the Clinical Directors take up their posts.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 16/05/2019 15:49:49 answering member 4455 label Biography information for Seema Kennedy
	tabling member	4657 label Biography information for Anneliese Dodds

1126166

	registered interest
	date	13/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Department of Health and Social Care: Retirement
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what support his Department provides to staff in his Department (a) in their transition to retirement and (b) to (i) maintain and (ii) increase the physical and mental wellbeing staff planning for retirement.
	tabling member constituency	Vale of Clwyd
	tabling member printed	Chris Ruane
	uin	253516
	answer	answer is ministerial correction date of answer 16/05/2019 answer text <p>Departmental support for staff transitioning into retirement includes a Pre Retirement learning event, provided via Civil Service Learning, which raises awareness of available information and resources, supports proactive planning for making the most of retirement and awareness of how to claim Civil Service and state pensions.</p><p>All staff in the Department who are part of the Civil Service Pension Scheme, have access to MyCSP, the Civil Service pension provider, which provides online resources and tools, such as the Retirement Modeller and a Pension Portal and also provides individual pension advice over the phone.</p><p>The Department also offers and wherever possible, supports staff requests for partial retirement to support individual needs and also as a transition to future retirement.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 16/05/2019 11:24:44 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	534 label Biography information for Chris Ruane

1126266

	registered interest
	date	13/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Insulin
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether stocks of insulin will continue to be stockpiled to prepare for the UK leaving the EU without a deal.
	tabling member constituency	Edinburgh West
	tabling member printed	Christine Jardine
	uin	253706
	answer	answer is ministerial correction date of answer 16/05/2019 answer text <p>The Department fully understands that maintaining access to insulin is vitally important to many people in this country.</p><p>The Government remains committed to leaving the European Union with a deal. We have now reached agreement with the EU on an extension to the Article 50 period until 31 October at the latest, with the option to leave earlier as soon as a Withdrawal Agreement has been ratified.</p><p>Under the terms of the Withdrawal Agreement, there will be an implementation period running till the end of 2020, during which there will be no changes to the current trading arrangements with the EU. Therefore, if the Withdrawal Agreement is ratified, the supply of medicines will continue on the same basis it does now during this period.</p><p>Leaving without a deal remains the legal default at the end of the extension period if no Withdrawal Agreement is agreed. Therefore, as a responsible Government, we will continue to prepare to minimise any disruption to the supply of medicines and medical products in a potential ‘no deal’ scenario.</p><p>We are continuing to work with trade bodies and other stakeholders to review the position carefully before sharing further guidance at the earliest opportunity. Stockpiled medicines were not procured by the Department as part of our ‘no deal’ plans and remain the property of medicines suppliers. On 26 April we wrote to pharmaceutical companies, including those who supply insulin, asking in the meantime, that all ‘no deal’ measures (such as stockpiles, additional buffer stocks etc) should remain in place but on hold until further guidance is available.</p><p>We are confident that if everyone, including suppliers, freight companies, our European neighbours, and the health and care system, does what they need to do, the supply of medicines and medical products should be uninterrupted in the event we leave the EU without a deal.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 16/05/2019 11:27:54 answering member 1585 label Biography information for Stephen Hammond
	tabling member	4634 label Biography information for Christine Jardine

1126267

	registered interest
	date	13/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Insulin
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the amount of insulin procured before 29 March 2019 as part of preparations for the UK leaving the EU without a deal that has been (a) destroyed, (b) redistributed and (c) sold back to manufacturers.
	tabling member constituency	Edinburgh West
	tabling member printed	Christine Jardine
	uin	253707
	answer	answer is ministerial correction date of answer 16/05/2019 answer text <p>The Department fully understands that maintaining access to insulin is vitally important to many people in this country.</p><p>The Government remains committed to leaving the European Union with a deal. We have now reached agreement with the EU on an extension to the Article 50 period until 31 October at the latest, with the option to leave earlier as soon as a Withdrawal Agreement has been ratified.</p><p>Under the terms of the Withdrawal Agreement, there will be an implementation period running till the end of 2020, during which there will be no changes to the current trading arrangements with the EU. Therefore, if the Withdrawal Agreement is ratified, the supply of medicines will continue on the same basis it does now during this period.</p><p>Leaving without a deal remains the legal default at the end of the extension period if no Withdrawal Agreement is agreed. Therefore, as a responsible Government, we will continue to prepare to minimise any disruption to the supply of medicines and medical products in a potential ‘no deal’ scenario.</p><p>We are continuing to work with trade bodies and other stakeholders to review the position carefully before sharing further guidance at the earliest opportunity. Stockpiled medicines were not procured by the Department as part of our ‘no deal’ plans and remain the property of medicines suppliers. On 26 April we wrote to pharmaceutical companies, including those who supply insulin, asking in the meantime, that all ‘no deal’ measures (such as stockpiles, additional buffer stocks etc) should remain in place but on hold until further guidance is available.</p><p>We are confident that if everyone, including suppliers, freight companies, our European neighbours, and the health and care system, does what they need to do, the supply of medicines and medical products should be uninterrupted in the event we leave the EU without a deal.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 16/05/2019 11:29:34 answering member 1585 label Biography information for Stephen Hammond
	tabling member	4634 label Biography information for Christine Jardine

1126022

	registered interest
	date	13/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	National Institute for Health and Care Excellence
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will expedite the process by which the NICE publishes its decisions.
	tabling member constituency	Stroud
	tabling member printed	Dr David Drew
	uin	253483
	answer	answer is ministerial correction date of answer 21/05/2019 answer text <p>The Government wants patients to be able to benefit from access to effective new treatments as quickly as possible.</p><p>Through its technology appraisal and highly specialised technologies guidance, the National Institute for Health and Care Excellence (NICE) makes authoritative, evidence-based recommendations on whether medicines and other treatments represent a clinically and cost effective use of National Health Service resources. NHS organisations are legally required to make funding available for NICE recommended treatments, usually within three months of final guidance.</p><p>Wherever possible, NICE currently aims to publish recommendations on new drugs as soon as possible after licensing, with draft guidance on cancer drugs published in advance of licensing. The 2019 Voluntary Scheme for Branded Medicines Pricing and Access includes a commitment to faster NICE assessments of new medicines, with timelines for non-cancer drugs to match those for cancer drugs, subject to the evidence base for the product being sufficiently developed.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 21/05/2019 10:58:38 answering member 4455 label Biography information for Seema Kennedy
	tabling member	252 label Biography information for Dr David Drew